Strategic Promotion of ENTEX Formulations

WraSer Pharmaceuticals, LLC to launch key ENTEX formulations. RIDGELAND, MS March 13, 2012 WraSer Pharmaceuticals, LLC (WraSer) a privately held Ridgeland, Mississippi based pharmaceutical company, is pleased to announce the development and launch of the successful brand, ENTEX to reinforce its commitment to otolaryngologists, (ear, nose and throat doctors). WraSer Pharmaceuticals will target key otolaryngologists and primary care medical practitioners to increase the market for ENTEX oral tablets and liquid, the expectorant containing medications (Guaifenesin, USP) makes phlegm easier to cough up; Guaifenesin is also the only approved expectorant on the market, which is supposed to help loosen lung secretions and make them easier to cough up. Key formulations are currently available nationally through healthcare provider prescriptions, wholesale & pharmacy distribution, and available online at www.wraser.com. We are very excited to reintroduce the well known brand ENTEX, to the otolaryngologist and primary care providers we serve, said Ford Mundy, Vice President of Brands for WraSer Pharmaceuticals. We believe that we can significantly increase the value of this brand and the platform gives our company future avenues to pursue such as true over-the-counter availability through national pharmacy chains. About WraSer Pharmaceuticals, LLC WraSer Pharmaceuticals, LLC (Wraser), based in Ridgeland, MS, is a specialty pharmaceutical company engaged in the development and marketing of prescription pharmaceutical products. Founded in 2002, WraSer has built a strong presence in the pharmaceutical markets by offering a variety of innovative, affordable products to medical practitioners and their patients. For more information, please visit www.wraser.com.

Posted on 3/13/2012

View All Postings